234 related articles for article (PubMed ID: 11447309)
1. Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.
Krum H; Denver R; Tzanidis A; Martin P
Heart Fail Rev; 2001 Dec; 6(4):341-52. PubMed ID: 11447309
[TBL] [Abstract][Full Text] [Related]
2. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with endothelin receptor antagonists in chronic heart failure.
Seed A; Love MP; McMurray JJ
Heart Fail Rev; 2001 Dec; 6(4):317-23. PubMed ID: 11447306
[TBL] [Abstract][Full Text] [Related]
4. Endothelin antagonists and heart failure.
Hürlimann D; Enseleit F; Noll G; Lüscher TF; Ruschitzka F
Curr Hypertens Rep; 2002 Feb; 4(1):85-92. PubMed ID: 11790297
[TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
Heart Fail Rev; 2001 Dec; 6(4):301-15. PubMed ID: 11447305
[TBL] [Abstract][Full Text] [Related]
6. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
8. Endothelin and heart failure.
Nambi P; Clozel M; Feuerstein G
Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308
[TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ
Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663
[TBL] [Abstract][Full Text] [Related]
11. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
[TBL] [Abstract][Full Text] [Related]
13. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of bosentan in patients with chronic heart failure.
Kiowski W; Sütsch G; Oechslin E; Bertel O
Heart Fail Rev; 2001 Dec; 6(4):325-34. PubMed ID: 11447307
[TBL] [Abstract][Full Text] [Related]
15. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one?
Monge JC
J Cardiovasc Pharmacol; 1998; 32 Suppl 2():S36-42. PubMed ID: 9736439
[TBL] [Abstract][Full Text] [Related]
17. [Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Salomon P; Przewłocka-Kosmala M; Orda A
Pol Arch Med Wewn; 2003 Jan; 109(1):43-8. PubMed ID: 12879765
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
[TBL] [Abstract][Full Text] [Related]
19. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
20. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
